The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Antibiotics for cancer treatment: A double-edged sword
Open accessAbstract
Various antibiotics have been used in the treatment of cancers, via their anti-proliferative, pro-apoptotic and anti-epithelial-mesenchymal-transition (EMT) capabilities. However, increasingly studies have indicated that antibiotics may also induce cancer generation by disrupting intestinal microbiota, which further promotes chronic inflammation, alters normal tissue metabolism, leads to genotoxicity and weakens the immune response to bacterial malnutrition, thereby adversely impacting cancer treatment. Despite the advent of high-throughput sequencing technology in recent years, the potential adverse effects of antibiotics on cancer treatments via causing microbial imbalance has been largely ignored. In this review, we discuss the double-edged sword of antibiotics in the field of cancer treatments, explore their potential mechanisms and provide solutions to reduce the potential negative effects of antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
International Journal of Molecular Sciences
(2024) · International Journal of Molecular Sciences · doi:10.3390/ijms · Cited by 10,111
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
The resilience of the intestinal microbiota influences health and disease
Sommer, F., Anderson, J. M., Bharti, R., Raes, J., & Rosenstiel, P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.58 · Cited by 1,058
Doxorubicin-Induced Cardiomyopathy
Takemura, G., & Fujiwara, H. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.10.002 · Cited by 827
Effect of antimicrobial agents on the ecological balance of human microflora
Sullivan, Å., Edlund, C., & Nord, C. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00066-4 · Cited by 818
EMT, CTCs and CSCs in tumor relapse and drug-resistance
Mitra, A., Mishra, L., & Li, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4037 · Cited by 465
Dong, C., Wu, Y., Yao, J., Wang, Y., Yu, Y., Rychahou, P. G., Evers, B. M., & Zhou, B. P. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57349 · Cited by 464
Shapiro, T. A., Fahey, J. W., Wade, K. L., Stephenson, K. K., & Talalay, P. (1998) · PubMed · Cited by 424
The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession.
Reuter, G. (2001) · PubMed · Cited by 416
McEachran, A. D., Blackwell, B. R., Hanson, J. D., Wooten, K. J., Mayer, G. D., Cox, S. B., & Smith, P. N. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1408555 · Cited by 371
Immunomodulatory effects of quinolones
Dalhoff, A., & Shalit, I. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00658-3 · Cited by 310
Tomasz, M., & Palom, Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00088-0 · Cited by 283
Waters, J. S., Norman, A., Cunningham, D., Scarffe, J. H., Webb, A., Harper, P., Joffe, J. K., Mackean, M., Mansi, J., Leahy, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690350 · Cited by 275
International Journal of Gynecological Cancer
(2024) · International Journal of Gynecological Cancer · doi:10.1111/(issn)1525-1438 · Cited by 219
Anthracycline Antibiotics in Cancer Therapy: Focus on Drug Resistance
Booser, D. J., & Hortobagyi, G. N. (1994) · Drugs · doi:10.2165/00003495-199447020-00002 · Cited by 214
Intestinal microbiota: a potential target for the treatment of postmenopausal osteoporosis
Xu, X., Jia, X., Mo, L., Liu, C., Zheng, L., Yuan, Q., & Zhou, X. (2017) · Bone Research · doi:10.1038/boneres.2017.46 · Cited by 199
Jiang, C., Wang, H., Xia, C., Dong, Q., Chen, E., Qiu, Y., Su, Y., Xie, H., Zeng, L., Kuang, J., et al. (2019) · Cancer · doi:10.1002/cncr.31907 · Cited by 188
Self-citationJournal of Physiology and Biochemistry
(2013) · Journal of Physiology and Biochemistry · doi:10.1007/13105.1877-8755 · Cited by 180
Preoperative Probiotics Decrease Postoperative Infectious Complications of Colorectal Cancer
Zhang, J.-W., Du, P., Yang, B.-R., Gao, J., Fang, W.-J., & Ying, C.-M. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31823aace6 · Cited by 177
Peloquin, C. A. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100083020 · Cited by 167
Dersch, P., Khan, M. A., Mühlen, S., & Görke, B. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00803 · Cited by 156
Stem cells, senescence, neosis and self-renewal in cancer.
Rajaraman, R., Guernsey, D. L., Rajaraman, M. M., & Rajaraman, S. R. (2006) · Cancer Cell International · doi:10.1186/1475-2867-6-25 · Cited by 153
Grivennikov, S. I., Karin, E., Terzić, J., Mucida, D., Yu, G., Vallabhapurapu, S., Scheller, J., Rose‐John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.003 · Cited by 142
Sànchez‐Tilló, E., Fanlo, L., Siles, L., Montes‐Moreno, S., Moros, A., Chiva‐Blanch, G., Estruch, R., Martínez, A., Colomer, D., Győrffy, B., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.123 · Cited by 139
Combined Hyperthermia and Radiotherapy for the Treatment of Cancer
Kaur, P., Hurwitz, M., Krishnan, S., & Asea, A. A. A. (2011) · Cancers · doi:10.3390/cancers3043799 · Cited by 130
Antibiotic use predicts an increased risk of cancer
Kilkkinen, A., Rissanen, H. A., Klaukka, T., Pukkala, ., Heliövaara, M., Huovinen, P., Männistö, S., Aromaa, A., & Knekt, P. (2008) · International Journal of Cancer · doi:10.1002/ijc.23622 · Cited by 122
Beberok, A., Wrześniok, D. M., Rok, J., Rzepka, Z., Respondek, M., & Buszman, E. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4310 · Cited by 110
Evolution, Nutrition, Intestinal Microflora, and Prevention of Cancer: A Hypothesis
Adlercreutz, H. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-217-44228 · Cited by 108
Zhou, J., Li, P., Xue, X., He, S., Kuang, Y., Zhao, H., Chen, S., Zhi, Q., & Guo, X. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.07.022 · Cited by 101
Impact of antibiotic exposure on the risk of colorectal cancer
Boursi, B., Haynes, K., Mamtani, R., & Yang, Y. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3765 · Cited by 96
Fluoroquinolone induction of phage-mediated gene transfer in multidrug-resistant Salmonella
Bearson, B. L., & Brunelle, B. W. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.04.008 · Cited by 95
Zheng, C., Chen, T., Wang, Y., Gao, Y., Kong, Y., Liu, Z., & Deng, X. (2019) · Journal of Cancer · doi:10.7150/jca.29072 · Cited by 94
Self-citationThe Interaction of the Metallo-Glycopeptide Anti-Tumour Drug Bleomycin with DNA
Murray, V., Chen, J. K., & Chung, L. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051372 · Cited by 90
Al-Aamri, H. M., Ku, H., Irving, H. R., Tucci, J., Meehan-Andrews, T., & Bradley, C. (2019) · BMC Cancer · doi:10.1186/s12885-019-5377-y · Cited by 89
Attur, M. G., Patel, R. N., Patel, P. D., Abramson, S. B., & Amin, A. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3160 · Cited by 88
Patel, R. N., Attur, M. G., Dave, M. N., Patel, I. V., Stuchin, S. A., Abramson, S. B., & Amin, A. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3459 · Cited by 86
Kuczma, M., Ding, Z., Li, T., Habtetsion, T. G., Chen, T., Hao, Z., Bryan, L. J., Singh, N., Kochenderfer, J. N., & Zhou, G. (2017) · Oncotarget · doi:10.18632/oncotarget.22953 · Cited by 76
Self-citationHow avastin potentiates chemotherapeutic drugs: Action and reaction in antiangiogenic therapy
Blagosklonny, M. V. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.12.2315 · Cited by 74
Beberok, A., Wrześniok, D. M., Minecka, A., Rok, J., Delijewski, M., Rzepka, Z., Respondek, M., & Buszman, E. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.07.007 · Cited by 63
Salinomycin inhibits Akt/NF-κB and induces apoptosis in cisplatin resistant ovarian cancer cells
Parajuli, B., Lee, H.-G., Kwon, S., Cha, S.-D., Shin, S., Lee, G.-H., Bae, I., & Cho, C. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2013.02.008 · Cited by 61
Xipell, E., Aragón, T., Martínez-Vélez, N., Vera, B., Idoate, M. A., Martínez-Irujo, J. J., García-Garzón, A., González-Huarriz, M., de la Rocha, A. A., Jones, C., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now022 · Cited by 61
Xiao, Z., Sperl, B., Ullrich, A., & Knyazev, P. G. (2014) · Oncotarget · doi:10.18632/oncotarget.2657 · Cited by 56
Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell
Lee, H.-G., Shin, S., Chung, H., Kwon, S., Cha, S.-D., Lee, J.-E., & Cho, C. (2016) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2017.28.e14 · Cited by 55
Thurlimann, B. J. K., Waldburger, R., Senn, H.-J., & Thiébaud, D. (1992) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058287 · Cited by 51
Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazine.
Ga, V. H., Rubin, J., & Cg, M. (1983) · PubMed · Cited by 51
Fox, K. R., Waring, M. J., Brown, J. R., & Neidle, S. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80703-7 · Cited by 45
Prouvot, C., Golfier, F., Massardier, J., You, B., Lotz, J., Patrier, S., Devouassoux‐Shisheboran, M., Schott, A., Hajri, T., & Bolze, P. (2018) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001248 · Cited by 44
Hashem, H., El‐Hafeez, A. A. A., Abbas, S. H., Abdelhafez, E. M. N., & Abuo‐Rahma, G. E. A. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.07.070 · Cited by 43
Production of Antibiotics and other Commercially Valuable Secondary Metabolites
Barrios-González, J., & Mejía, A. (2008) · Springer eBooks · doi:10.1007/978-0-387-75213-6_14 · Cited by 33
Investigations into the DNA-binding mode of doxorubicinone
Tartakoff, S. S., Finan, J. M., Curtis, E. J., Anchukaitis, H. M., Couture, D. J., & Glazier, S. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob02344a · Cited by 30
Intestinal microflora as a therapeutic target in inflammatory bowel disease
Mitsuyama, K., Toyonaga, A., & Sata, M. (2002) · Journal of Gastroenterology · doi:10.1007/bf03326418 · Cited by 29
Appelbaum, P. C., Gillespie, S. H., Burley, C. J., & Tillotson, G. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.02.017 · Cited by 28
The need for prudent use of antibiotics and routine use of vaccines
Cohen, R. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02727.x · Cited by 20
Evaluation of serum alkaline phosphatase determination in patients with positive bone scans
Cowan, R. J., & Young, K. A. (1973) · Cancer · doi:10.1002/1097-0142(197310)32:4<735::aid-cncr2820320401>3.0.co;2-k · Cited by 18
Therapy Insight: fertility in women after cancer treatment
Morice, P., Pautier, P., Fanchin, R. R. F., Haie-Méder, C., Chauveaud-Lambling, A., Frydman, R., & Frydman, N. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0675 · Cited by 11
Dees, A., Verweij, J., van Putten, W. L. J., et al. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90118-0 · Cited by 3
Cited by
Mitochondrial RNA modifications shape metabolic plasticity in metastasis
Delaunay, S., Pascual, G., Feng, B., Klann, K., Behm, M., Hotz-Wagenblatt, A., Richter, K., Zaoui, K., Herpel, E., Münch, C., et al. (2022) · Nature · doi:10.1038/s41586-022-04898-5 · Cited by 303
Targeting the gut microbiota for cancer therapy
Fernandes, M. R., Aggarwal, P., Costa, R. G. F., Cole, A. M., & Trinchieri, G. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00513-x · Cited by 290
Gut microbiota-mediated immunomodulation in tumor
Liu, X., Chen, Y., Zhang, S., & Dong, L. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01983-x · Cited by 112
Enhancing autophagy in Alzheimer's disease through drug repositioning
Eshraghi, M., Ahmadi, M., Afshar, S., Lorzadeh, S., Adlimoghaddam, A., Rezvani Jalal, N., West, R., Dastghaib, S., Igder, S., Torshizi, S. R. N., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108171 · Cited by 89
Lam, H. Y. P., Lai, M.-J., Wang, P.-C., Wu, W.-J., Chen, L.-K., Fan, H.-W., Tseng, C.-C., Peng, S.-Y., & Chang, K.-C. (2025) · Antibiotics · doi:10.3390/antibiotics14010045 · Cited by 29
Metadata
- Authors
- Gao, Y., Shang, Q., Li, W., Guo, W., Stojadinovic, A., Mannion, C., Man, Y.-G., & Chen, T.
- Venue
- Journal of Cancer
- Publisher
- Ivyspring International Publisher
- Published
- 2020
- Volume
- 11
- Issue
- 17
- Pages
- 5135-5149
- ISSN
- 1837-9664 (ISSN-L)
- OpenAlex
- W3043831675
- Cited by
- 253
- References
- 59
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
